New prostate cancer drug enters human testing

NCT ID NCT07181161

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing a new drug called AZD0516 for men with advanced prostate cancer that has spread. Researchers want to find a safe dose and see if the drug, given alone or with other cancer treatments, can help control the disease. The study will enroll about 177 participants to check for side effects and early signs that the treatment is working.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
RECRUITING

Fayetteville, Arkansas, 72703, United States
Research Site
NOT_YET_RECRUITING

Los Angeles, California, 90095, United States
Research Site
NOT_YET_RECRUITING

Boston, Massachusetts, 02114, United States
Research Site
RECRUITING

Ann Arbor, Michigan, 48109, United States
Research Site
RECRUITING

Detroit, Michigan, 48201, United States
Research Site
NOT_YET_RECRUITING

Buffalo, New York, 14263, United States
Research Site
RECRUITING

New York, New York, 10065, United States
Research Site
RECRUITING

Providence, Rhode Island, 02906, United States
Research Site
RECRUITING

Myrtle Beach, South Carolina, 29572, United States
Research Site
RECRUITING

Houston, Texas, 77030, United States
Research Site
NOT_YET_RECRUITING

Barretos, 14784-400, Brazil
Research Site
NOT_YET_RECRUITING

Porto Alegre, 90035-001, Brazil
Research Site
NOT_YET_RECRUITING

São Paulo, 01401-002, Brazil
Research Site
NOT_YET_RECRUITING

Changsha, 410013, China
Research Site
NOT_YET_RECRUITING

Chengdu, 610041, China
Research Site
NOT_YET_RECRUITING

Wuhan, 430022, China
Research Site
WITHDRAWN

Lyon, 69008, France
Research Site
WITHDRAWN

Montpellier, 34298, France
Research Site
WITHDRAWN

Saint-Herblain, 44805, France
Research Site
WITHDRAWN

Suresnes, 92151, France
Research Site
WITHDRAWN

Villejuif, 94805, France
Research Site
NOT_YET_RECRUITING

Milan, 20132, Italy
Research Site
NOT_YET_RECRUITING

Milan, 20133, Italy
Research Site
NOT_YET_RECRUITING

Milan, 20141, Italy
Research Site
NOT_YET_RECRUITING

Naples, 80131, Italy
Research Site
NOT_YET_RECRUITING

Roma, 00168, Italy
Research Site
NOT_YET_RECRUITING

Rozzano, 20089, Italy
Research Site
RECRUITING

Chūōku, 104-0045, Japan
Research Site
NOT_YET_RECRUITING

Kashiwa, 277-8577, Japan
Research Site
RECRUITING

Kōtoku, 135-8550, Japan
Research Site
NOT_YET_RECRUITING

Koszalin, 75-581, Poland
Research Site
NOT_YET_RECRUITING

Piotrkow Trybunalski, 97-300, Poland
Research Site
NOT_YET_RECRUITING

Przemyśl, 37-700, Poland
Research Site
NOT_YET_RECRUITING

Seoul, 03080, South Korea
Research Site
NOT_YET_RECRUITING

Seoul, 03722, South Korea
Research Site
NOT_YET_RECRUITING

Seoul, 06351, South Korea
Research Site
NOT_YET_RECRUITING

Seoul, 06591, South Korea
Research Site
NOT_YET_RECRUITING

Seoul, 5505, South Korea
Research Site
NOT_YET_RECRUITING

Barcelona, 08035, Spain
Research Site
NOT_YET_RECRUITING

Barcelona, 08036, Spain
Research Site
NOT_YET_RECRUITING

Barcelona, 08041, Spain
Research Site
NOT_YET_RECRUITING

L'Hospitalet de Llobregat, 08908, Spain
Research Site
NOT_YET_RECRUITING

Madrid, 28027, Spain
Research Site
NOT_YET_RECRUITING

Pamplona, 31005, Spain
Research Site
NOT_YET_RECRUITING

Santander, 39008, Spain
Research Site
NOT_YET_RECRUITING

Valencia, 46009, Spain
Research Site
NOT_YET_RECRUITING

Cambridge, CB2 0QQ, United Kingdom
Research Site
NOT_YET_RECRUITING

London, EC1A 7BE, United Kingdom
Research Site
NOT_YET_RECRUITING

London, SE1 9RT, United Kingdom
Research Site
RECRUITING

Plymouth, PL6 8DH, United Kingdom
Research Site
RECRUITING

Sutton, SM2 5PT, United Kingdom

Conditions

Explore the condition pages connected to this study.

METASTATIC PROSTATE CANCER